Correlation Between Briacell Therapeutics and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Briacell Therapeutics and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Briacell Therapeutics and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Briacell Therapeutics Corp and Fate Therapeutics, you can compare the effects of market volatilities on Briacell Therapeutics and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Briacell Therapeutics with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Briacell Therapeutics and Fate Therapeutics.
Diversification Opportunities for Briacell Therapeutics and Fate Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Briacell and Fate is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Briacell Therapeutics Corp and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Briacell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Briacell Therapeutics Corp are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Briacell Therapeutics i.e., Briacell Therapeutics and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Briacell Therapeutics and Fate Therapeutics
Given the investment horizon of 90 days Briacell Therapeutics Corp is expected to generate 1.91 times more return on investment than Fate Therapeutics. However, Briacell Therapeutics is 1.91 times more volatile than Fate Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 63.00 in Briacell Therapeutics Corp on September 24, 2024 and sell it today you would lose (8.91) from holding Briacell Therapeutics Corp or give up 14.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.46% |
Values | Daily Returns |
Briacell Therapeutics Corp vs. Fate Therapeutics
Performance |
Timeline |
Briacell Therapeutics |
Fate Therapeutics |
Briacell Therapeutics and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Briacell Therapeutics and Fate Therapeutics
The main advantage of trading using opposite Briacell Therapeutics and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Briacell Therapeutics position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Briacell Therapeutics vs. Fate Therapeutics | Briacell Therapeutics vs. Sana Biotechnology | Briacell Therapeutics vs. Caribou Biosciences | Briacell Therapeutics vs. Arcus Biosciences |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |